Trial Outcomes & Findings for Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction (NCT NCT03105518)

NCT ID: NCT03105518

Last Updated: 2022-08-03

Results Overview

Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.

Recruitment status

UNKNOWN

Study phase

PHASE4

Target enrollment

100 participants

Primary outcome timeframe

PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3

Results posted on

2022-08-03

Participant Flow

Participant milestones

Participant milestones
Measure
Analgesia Options
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg. Fentanyl: 0.5, 1 mcg/kg Acetaminophen: Single + Oxycodone Oxycodone: With Acetaminophen
Overall Study
STARTED
100
Overall Study
COMPLETED
100
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg. Fentanyl: 0.5, 1 mcg/kg Acetaminophen: Single + Oxycodone Oxycodone: With Acetaminophen
Age, Continuous
35.54 years
STANDARD_DEVIATION 4.61 • n=99 Participants
Sex: Female, Male
Female
100 Participants
n=99 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
95 Participants
n=99 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
5 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=99 Participants
Race (NIH/OMB)
White
90 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants

PRIMARY outcome

Timeframe: PACU admission, 15, 30 and 60 min postprocedure, postoperative day 3

Population: On PACU admission, subjects were divided into three groups based on the intensity of discomfort. A standardized postoperative analgesic regimen followed, based on VAS score and time (≤ or \> than 30 min).

Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale). VAS scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort.

Outcome measures

Outcome measures
Measure
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg. Fentanyl: 0.5, 1 mcg/kg Acetaminophen: Single + Oxycodone Oxycodone: With Acetaminophen
Amount of Discomfort
Time 0; ≤10 Follicles
1.53 units on a scale
Standard Deviation 2.13
Amount of Discomfort
Time 0; > 10 Follicles
3.25 units on a scale
Standard Deviation 2.9
Amount of Discomfort
Time 15; ≤10 Follicles
2.68 units on a scale
Standard Deviation 2.19
Amount of Discomfort
Time 15; >10 Follicles
3.61 units on a scale
Standard Deviation 1.98
Amount of Discomfort
Time 30; ≤10 Follicles
1.66 units on a scale
Standard Deviation 1.40
Amount of Discomfort
Time 30; >10 Follicles
2.93 units on a scale
Standard Deviation 1.43
Amount of Discomfort
Time 60; ≤10 Follicles
0.97 units on a scale
Standard Deviation 1.16
Amount of Discomfort
Time 60; >10 Follicles
2.19 units on a scale
Standard Deviation 1.55
Amount of Discomfort
Time POD 3; ≤ 10 Follicles
1.44 units on a scale
Standard Deviation 1.15
Amount of Discomfort
Time POD 3; > 10 Follicles
1.64 units on a scale
Standard Deviation 1.82

SECONDARY outcome

Timeframe: After 1 hrs but less than 3 days

Population: All 100 parturients analyzed; divided into those who had less than, compared to more than 10 follicles on preoperative ultrasound image.

Change in discomfort following oocyte retrieval with standardized anesthesia management as measured by verbal analogue scoring (0-10 scale) after immediate postoperative period (1 hrs) but prior to Embryo Transfer on 3rd postoperative day. Visual Analogue Scale (VAS) scores correlate to minimal (VAS 0-3), moderate (VAS 4-6) or severe (VAS ≥7) discomfort. Patients will record the type, dose, and timing of pain medicines in a diary to be returned at Embryo Transfer.

Outcome measures

Outcome measures
Measure
Analgesia Options
n=100 Participants
Protocolized analgesia based on VAS degree of discomfort and time. Analgesic options include heating pad, acetaminophen, percocet (oxycodone), fentanyl 0.5-1 mcg/kg. Fentanyl: 0.5, 1 mcg/kg Acetaminophen: Single + Oxycodone Oxycodone: With Acetaminophen
Amount of Discomfort Following Discharge Until Embryo Transfer
POD1; ≤10 Folli
2.15 units on a scale
Standard Deviation 1.72
Amount of Discomfort Following Discharge Until Embryo Transfer
POD1; >10 Follicles
3.21 units on a scale
Standard Deviation 1.87
Amount of Discomfort Following Discharge Until Embryo Transfer
POD2; ≤10 Folli
1.28 units on a scale
Standard Deviation 1.89
Amount of Discomfort Following Discharge Until Embryo Transfer
POD2; >10 Folli
2.50 units on a scale
Standard Deviation 2.35

Adverse Events

Analgesia Options

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Lawrence Tsen, MD

Brigham and Women's Hospital/Harvard Medical School

Phone: 617.732.8216

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place